Introduction {#Sec1}
============

Duck plague caused by the duck plague virus (DPV) is an acute hemorrhagic disease that results in sizable economic losses in the avian industry worldwide due to the low egg laying rates and high mortality rates of infected ducks^[@CR1]--[@CR7]^.

DPV, a member of the alphaherpesvirus subfamily, has a genome consisting of linear double-stranded DNA comprising a unique long (UL) region, a unique short (US) region, a unique short internal repeat (IRS) region, and a unique short terminal repeat (TRS) region^[@CR2],[@CR3],[@CR8]^. The genomic arrangement pattern is UL-IRS-US-TRS. The Us5 gene is highly nonconserved in alphaherpesviruses, and Us5 genes have been described in other Alphaherpesvirinae subfamily members, including herpes simplex virus 1 (HSV-1)^[@CR9]^, equine herpesvirus-1 (EHV-1)^[@CR10],[@CR11]^, infectious laryngotracheitis virus (ILTV)^[@CR12]^, and varicella-zoster virus (VZV)^[@CR13]^. The Us5 protein does not play a role in virus replication and infection like most glycoproteins, but it can regulate the release of the subvirus^[@CR14],[@CR15]^. Many gene products of alphaherpesviruses, including Us5, have antiapoptotic functions^[@CR16]--[@CR20]^. The Us5 protein of HSV-1 inhibits apoptosis caused by Fas, UV and granzyme B^[@CR18]^. The regions of Us5 that inhibit apoptosis are the signal sequence, the extracellular domain and the transmembrane domain^[@CR21]^, but the antiapoptotic mechanism of Us5 is not clear. Based on the past experimental results, we just know that Us5 protein can regulate caspases, cause mitochondrial membrane potential decline, and promote the production of reactive oxygen species (ROS)^[@CR18],[@CR21]^.

Apoptosis is an important mechanism of host immune defense. The apoptotic process is mainly characterized by cell shrinkage, chromatin aggregation, and apoptotic body formation. Thus far, apoptosis has been shown to be induced by two classical pathways: the extrinsic and intrinsic apoptotic pathways. Caspases are cysteine proteases that are extremely important for intracellular apoptotic pathways, and caspase-9 and caspase-8 are involved in the intrinsic and extrinsic apoptotic pathways, respectively; both caspase-8 and caspase-9 activate the downstream molecule caspase-3 to initiate apoptosis. H~2~O~2~ is an apoptosis inducer that causes cells to undergo oxidative stress and increases intracellular ROS. ROS reduce the mitochondrial membrane potential and activate caspase-9, which subsequently activates the downstream molecule caspase-3^[@CR22]^.

Our laboratory has previously demonstrated that the function of DPV Us5 is slightly impaired in viral replication, virion assembly and cell-to-cell spread and that is not essential in virion envelopment^[@CR23]^. However, information regarding the DPV Us5 gene is limited. In this study, we further performed a molecular characterization and investigated the antiapoptotic function of the DPV Us5 gene. The results of this study will provide a foundation for studying the pathogenesis of DPV.

Results {#Sec2}
=======

Kinetics of DPV Us5 {#Sec3}
-------------------

The melting curves showed that the specificities of the primers were excellent, and standard curves were established to evaluate the efficiency of the assays (data not shown). The results showed that the Us5 gene transcript was detected at 6 hours post infection (hpi); Us5 expression gradually increased, peaking at 36 h, and then steadily decreased at 48 hpi, 54 hpi, and 60 hpi (Fig. [1A](#Fig1){ref-type="fig"}). As shown in Fig. [1B](#Fig1){ref-type="fig"}, a specific protein band of approximately 130 kDa was initially detected at 24 h. Peak expression occurred at 36 hpi, decreasing steadily thereafter, and Us5 was still detected at 60 hpi. The gene and protein expression levels of DPV Us5 are consistent with those of a late gene. To further verify the Us5 gene type, the protein synthesis inhibitor cyclohexamide (CHX) and the DNA polymerase inhibitor ganciclovir (GCV) were used to determine the kinetic class. Us5 (amplified length of 156 bp) and Us2 (amplified length of 111 bp, DPV late gene) were detected only when no drugs were present and there was no DPV infection (Fig. [2](#Fig2){ref-type="fig"}). Thus, Us5 is a late gene due to its strict dependence on the early synthesis of viral DNA and protein.Figure 1The transcription and expression kinetics of the DPV Us5 gene. (**A**) Relative transcript levels of the DPV Us5 gene at 6, 12, 24, 36, 48, 54, and 60 hpi. (**B**) Western blotting analysis for Us5 and β-actin at 6, 12, 24, 36, 48, 54, and 60 hpi (approximately 130 kDa) with anti-Us5 serum and anti-β-actin serum.Figure 2Pharmaceutical identification of virion gene type. M: DL2000 marker; 1: DEV-infected cells treated with 50 μg/ml cycloheximide (CHX); 2: DEV-infected cells treated with 300 μg/mL ganciclovir (GCV); 3: DPV-infected cells without drugs; 4: untreated DEF cells. The DPV Us5 gene (156 bp) and the L gene Us2 (111 bp) are shown.

Subcellular localization of DPV Us5 {#Sec4}
-----------------------------------

The results showed that Us5 protein-specific fluorescence, which is indicated in green (FITC), was localized primarily in the cytoplasm at 12 hpi. As time progressed, Us5 protein-specific fluorescence was localized mainly in the cytoplasm at 12 hpi, 24 hpi, 36 hpi, 48 hpi, 54 hpi, and 60 hpi. However, little Us5 protein-specific fluorescence was located in the perinuclear region at 36 hpi and 48 hpi. In contrast, no fluorescence was observed in the control groups. The nuclei are indicated in blue (DAPI), and cytoskeleton are indicated red (Phalloidin) (Fig. [3](#Fig3){ref-type="fig"}).Figure 3Dynamic intracellular localization of the Us5 protein during DPV infection at different times. Fluorescence microscopic images of Us5 localization (green in all images) at 6, 12, 24, 36, 48, 54 and 60 hpi. Nuclei are indicated in blue (DAPI) and cytoskeleton are indicated red (Phalloidin).

The DPV Us5 protein is a component of the virion {#Sec5}
------------------------------------------------

We identified 40 structural proteins in the purified DPV virions (data not shown), including the DPV Us5 protein. Two unique DPV Us5 peptides were detected, while three unique peptides matched DPV gC (P \< 0.05). The relative abundance of Us5 was low based on the exponentially modified protein abundance index (emPAI) (Table [1](#Tab1){ref-type="table"}). As shown in Fig. [4](#Fig4){ref-type="fig"}, the Us5 protein could be detected in DPV-infected cells and purified virions.Table 1Viral content of DPV extracellular virions (partial).ProteinDescriptionScoreMassMatchesSequencesemPAINCBI AccessionUL44glycoprotein C9747,8366 (3)6 (3)0.22AJG04885.1Us5glycoprotein J3161,4756 (2)5 (2)0.11ADU04075.1Figure 4The Us5 protein is a component of the virion, as determined by Western blotting.

H~2~O~2~ induces apoptosis of DEF cells {#Sec6}
---------------------------------------

The results showed that the H~2~O~2~-treated cells were shrunken, detached, rounded and had lost adherence (Fig. [5A](#Fig5){ref-type="fig"}). Compared to those of untreated cells, the nuclei of H~2~O~2~-treated cells were smaller and distorted; in addition, chromatin was collected on the nuclear membrane and apoptotic bodies appeared (Fig. [5B](#Fig5){ref-type="fig"}). Positive TUNEL staining, a hallmark of apoptotic cell death, was detected in H~2~O~2~-treated cells, whereas non-H~2~O~2~-treated cells were negative for TUNEL staining (Fig. [5C](#Fig5){ref-type="fig"}). In addition, Flow Cytometry results indicated that H~2~O~2~-treated cells have 22% apoptosis cells (Fig. [6C](#Fig6){ref-type="fig"}).Figure 5H~2~O~2~ induces apoptosis in DEF cells. (**A**) Cells were observed using phase contrast microscopy (×100). Non-H~2~O~2~-treated cells were used as controls (**B**). The cells were fixed and stained with DAPI. The arrows indicate apoptotic nuclei, and non-H~2~O~2~-treated cells were used as controls. (**C**) TUNEL assay. The arrows refer to TUNEL- positive cells, and non-H~2~O~2~-treated cells were used as controls.Figure 6Activity of caspase-3 and caspase-9 induced by H~2~O~2~ in DEF cells. (**A**) The mRNA expression levels of caspase-3 and caspase-9 in H~2~O~2~-treated and non-H~2~O~2~-treated cells. (**B**) The activity of caspase-3/7 and caspase-9 in H~2~O~2~**-**treated and non-H~2~O~2~-treated cells. All data are presented as the means ± SD from three individual experiments. Non-H~2~O~2~-treated cells were used as controls. p\* \< 0.05 compared to the non-H~2~O~2~-treated controls. (**C**) Flow Cytometry results indicated that H~2~O~2~-treated cells have 22% apoptosis cells.

H~2~O~2~ activates caspase-3 and caspase-9 in DEF cells {#Sec7}
-------------------------------------------------------

The mRNA level of caspase-3 in H~2~O~2~-treated cells was approximately 1.65 times that in untreated cells, and the mRNA level of caspase-9 in H~2~O~2~-treated cells was approximately 3 times that in untreated cells (Fig. [6A](#Fig6){ref-type="fig"}). H~2~O~2~ treatment of cells led to a significant increase in the activity of the caspase-3/7 and caspase-9 proteins (Fig. [6B](#Fig6){ref-type="fig"}). The luminescence values of caspase-3/7 and caspase-9 in untreated cells were 4.5 × 10^3^ RLU and 3.0 × 10^3^ RLU per ten thousand cells, respectively. The luminescence value of caspase 3/7 and caspase 9 in treated cells were 6.0 × 10^3^ RLU and 8.0 × 10^3^ RLU per ten thousand cells, respectively (Fig. [6B](#Fig6){ref-type="fig"}).

Expression of the recombinant plasmid pCAGGS-Us5 in DEF cells {#Sec8}
-------------------------------------------------------------

pCAGGS and pCAGGS-Us5 plasmids were transfected into DEFs. In Fig. [7A](#Fig7){ref-type="fig"}, fluorescence is indicated in green (FITC) in pCAGGS-Us5 plasmid-transfected cells. The expression of the pCAGGS-Us5 plasmids was detected by Western blotting, which showed approximately 130 kDa bands (Fig. [7B](#Fig7){ref-type="fig"}). Similarly, the expression of DPV Us5 was detected, and the Western blot showed approximately 130 kDa bands (Fig. [7C](#Fig7){ref-type="fig"}).Figure 7Expression of the Us5 protein in DEF cells. (**A**) Indirect immunofluorescence of DPV Us5 in DEF cells. Costaining was performed with a rabbit anti-DPV-Us5 polyclonal antibody and a fluorescein-conjugated goat anti-rabbit IgG antibody. (**B**) Western blotting of DPV Us5 in DEF cells. A rabbit anti-DPV-Us5 polyclonal antibody was used as the primary antibody. A goat anti-rabbit IgG (H + L)-HRP antibody was used as the secondary antibody. Noninfected cells were used as controls. (**C**) Western blotting of pCAGGS-Us5 in DEF cells. A duck anti-DPV polyclonal antibody was used as the primary antibody. A goat anti-duck IgG (H + L)-HRP antibody was used as the secondary antibody. Cells transfected with the pCAGGS plasmid were used as the controls.

DPV Us5 inhibits apoptosis induced by H~2~O~2~ in DEF cells {#Sec9}
-----------------------------------------------------------

Compared with that of H~2~O~2~-treated cells transfected with the pCAGGS plasmid, the positive TUNEL staining of H~2~O~2~-treated cells transfected with the pCAGGS-Us5 plasmid was significantly reduced (Fig. [8A](#Fig8){ref-type="fig"}). The results showed that the caspase-3/7 protein activity in H~2~O~2~-treated cells transfected with the pCAGGS plasmid was approximately 6 × 10^3^ RLU per ten thousand cells, while that of H~2~O~2~-treated cells transfected with the recombinant plasmid pCAGGS-Us5 was approximately 3.3 × 10^3^ RLU per ten thousand cells (Fig. [8B](#Fig8){ref-type="fig"}). The results also showed that the caspase-9 protein activity of H~2~O~2~-treated cells transfected with the pCAGGS plasmid was approximately 8.1 × 10^3^ RLU per ten thousand cells, and that of H~2~O~2~-treated cells transfected with the recombinant plasmid pCAGGS-Us5 was approximately 6 × 10^3^ RLU per ten thousand cells (Fig. [8B](#Fig8){ref-type="fig"}). As is shown in Fig. [8C](#Fig8){ref-type="fig"}, compared with that of H~2~O~2~-treated cells transfected with the pCAGGS plasmid, H~2~O~2~-treated cells transfected with the pCAGGS-Us5 plasmid cloud inhibit a lot of apoptosis.Figure 8Effect of the DPV Us5 protein on H~2~O~2~-induced apoptosis. (**A**) TUNEL assay. The arrows indicate TUNEL-positive cells. Cells transfected with the pCAGGS plasmid and treated with H~2~O~2~ were used as controls. (**B**) The activity of caspase-3/7 and caspase-9 in cells transfected with the pCAGGS-Us5 plasmid and treated with H~2~O~2~ and cells transfected with the pCAGGS plasmid and treated with H~2~O~2~. (**C**) H~2~O~2~-treated cells transfected with the pCAGGS-Us5 plasmid cloud inhibit a lot of apoptosis. All data are presented as the means ± SD from three individual experiments.  p\* \< 0.05, p\*\* \< 0.01 compared to the non-Us5-expressing control.

Anti-apoptosis ability of DPV CHv-BAC parental viruses, DPV CHv-BAC-ΔgJ mutant viruses and CHv-BAC-ΔgJR rescue viruses {#Sec10}
----------------------------------------------------------------------------------------------------------------------

According to the following results, we further explored whether Us5 could inhibit apoptosis induced in DPV infected cells. There have been reported that DPV CHv can cause DEF cells apoptosis^[@CR24]^, and we constructed the DPV CHv-BAC-ΔgJ mutant viruses successfully^[@CR23]^. Therefore, the DEF cells were infected with DPV-CHv, DPV CHv-BAC-ΔgJ mutant viruses and DPV CHv-BAC-ΔgJR rescue viruses respectively. The apoptosis DEF cells of recombination viruses relative to the parental virus were investigated at 48 hpi utilizing DAPI staining. As is shown in the Fig. [9A](#Fig9){ref-type="fig"}, the DPV CHv-BAC parental virus and the DPV CHv-BAC-ΔgJR rescue viruses induced apoptosis DEF cells that were similar in number. The apoptosis cells induced by DPV CHv-BAC-ΔgJ mutant viruses more than the parental virus. To better assess the apoptosis cells induced by different viruses, Flow Cytometry was analyzed the DEF Cells of apoptosis, this analysis also confirmed that the apoptosis cells induced by DPV CHv-BAC-ΔgJ mutant viruses more than the parental viruses (Fig. [9B](#Fig9){ref-type="fig"}).Figure 9Anti-apoptosis ability of DPV CHv-BAC parental viruses, DPV CHv-BAC-ΔgJ mutant viruses and CHv-BAC-ΔgJR rescueviruses. (**A**) The apoptosis DEF cells of recombination viruses relative to the parental virus were investigated at 48 hpi utilizing DAPI staining. (**B**) The apoptosis DEF cells of recombination viruses relative to the parental viruses were investigated at 48 hpi utilizing Flow Cytometry. All data are presented as the means ± SD from three individual experiments. p\* \< 0.05 compared to the DPV CHv-BAC parental viruses and the DPV CHv-BAC-ΔgJR rescue viruses.

Discussion {#Sec11}
==========

Until now, reports about the DPV Us5 gene have been limited. Our group constructed two different mutated viruses, a gJ deleted mutant, ΔgJ, and a rescue virus with gJ restored, ΔgJR, showing that the gJ was slightly impaired in viral replication, virion assembly and cell-to-cell spread and was not essential in virion envelopment^[@CR23]^. In this study, we further studied the function of DPV pUs5 as the first step in exploring the molecular characterization and antiapoptotic function of the DPV Us5 protein.

During herpesvirus infection, viral genes are expressed sequentially in three distinctly defined stages: immediate early gene (IE), early gene (E), and late gene (L). The IE genes are immediately transcribed upon infection, without interaction with other proteins^[@CR25]^. The E genes are transcribed prior to viral DNA replication in an IE protein-dependent manner. Transcription of the L genes begins after the synthesis of DNA, and viral protein translation begins^[@CR7],[@CR26]^. HSV-1 Us5 is a late gene, with partial dependency on DNA replication for its expression^[@CR21]^. The current study demonstrates that Us5 is similar to other HSV glycoproteins in that it is regulated as a late gene. To identify the DPV Us5 gene type, we used Western blot and RT-PCR analyses to study the expression and transcriptional kinetics of DPV Us5 at different time points after infection. Based on our group of previous studies^[@CR27]--[@CR31]^, we speculated that accumulation of the DPV Us5 protein may occur during the late stage of infection. The IE genes are expressed in the presence of the protein synthesis inhibitor CHX, while the transcription of the E and L genes is inhibited in the presence of CHX. To further study DPV Us5 gene, we treated infected cells with a protein synthesis inhibitor, CHX, and a DNA polymerase inhibitor, ganciclovir (GCV), and observed that the Us5 gene was inhibited in both the CHX and GCV groups.

Intracellular viral protein localization is associated with viral protein function, but intracellular DPV Us5 localization has thus far remained unclear. A previous publication demonstrated that Us5 was located on the surface of HSV-1-infected cells. Further studies showed that Us5, similar to other HSV glycoproteins, was mainly found in intracellular membranes, especially in Golgi bodies, the endoplasmic reticulum and endosomes^[@CR21]^. In this study, DPV infection in DEFs was detected by IFA. The results showed that DPV Us5 was mainly localized in the cytoplasm. Then, the recombinant plasmid pCAGGS-Us5 was transfected into DEF cells and revealed that Us5 was localized mainly in the cytoplasm. This finding indicates that Us5 modulates cellular functions occurring in the cytoplasm. DPV Us5 is a glycoprotein that may be differentially glycosylated to form different glycoproteins during posttranslational modification. The recombinant plasmid pCAGGS-Us5 was transfected into DEF cells and detected by Western blotting, which showed one specific band of approximately 130 kDa. Interestingly, the expression of Us5 after DPV infection in DEFs, as detected by Western blotting, also showed one specific band of approximately 130 kDa. The size of the Us5/gp2 protein encoded by the α-herpesvirus Us5 varies greatly among different viruses. The gp2 gene of equine herpesvirus-1 (EHV-1) is homologous to the Us5 gene and expresses three proteins with different molecular weights, 230 kDa, 65 kDa and 42 kDa^[@CR11]^; the Us5 and gD proteins of HSV-1 and the gG protein of Macacine herpesvirus-1 also have different molecular weights^[@CR21],[@CR32]^.

Viruses infect cells to facilitate their own breeding and to ensure their long-term survival in host cells, and viruses can evolve the necessary functions to prevent apoptosis and delay cell death. This ability to evolve is one of the biological characteristics of α-herpesviruses^[@CR33]^. Many studies have confirmed that α-herpesviruses encode proteins with antiapoptotic functions^[@CR16]--[@CR18],[@CR34]--[@CR36]^. During the early stage of infection, these genes promote the survival of host cells, facilitate the replication of the virus itself and facilitate the production of subviruses. One of the functions reported for the Us5 orthologs of HSV-1 is the inhibition of apoptosis induced by viral infection and exogenous factors^[@CR18],[@CR37]^. To study the antiapoptotic functions of DPV Us5 gene encoding protein, we first established an apoptotic model in which the apoptosis of DEF cells was induced by H~2~O~2~. There are many ways to induce cell apoptosis *in vitro*, such as with UV, sorbitol, and H~2~O~2~, among other methods^[@CR38]--[@CR41]^, and H~2~O~2~ has been used to establish apoptosis models in multiple cell types for antiapoptotic function experiments^[@CR42]--[@CR44]^. The morphology of the cells changed after treatment with 400 μM H~2~O~2~. These changes are consistent with the characteristics of apoptosis^[@CR45]^. In addition to examining morphology, detecting apoptotic factors is another classic way to verify apoptosis. In the apoptotic cascade, caspases, including caspase-3, are the major effectors of apoptosis^[@CR46]^. Therefore, to further verify that H~2~O~2~ induces DEF apoptosis, detection of the mRNA levels and activity of the apoptotic factor caspase-3 was necessary. In the current experiment, all of the data showed that the caspase-3 mRNA levels and activity were increased in H~2~O~2~-treated cells relative to those in control cells. These results prove the feasibility of hydrogen peroxide-induced DEF cells apoptosis. H~2~O~2~ induces apoptosis in various ways; including by increasing intracellular ROS levels. Excess intracellular ROS cause mitochondrial dysfunction, triggering the mitochondrial apoptotic pathway. This pathway activates cytochrome C, Apaf-1 and other factors and leads to the cleavage of downstream caspase-9, which activates other caspases, resulting in apoptosis^[@CR22],[@CR47]--[@CR49]^. In this study, the mRNA and activity levels of caspase-9 in H~2~O~2~-treated cells were significantly increased compared to those in control cells, suggesting that H~2~O~2~-induced apoptosis in DEF cells may be related to the mitochondrial pathway. This study is the first to show that DPV Us5 is necessary for the effective protection of cells against apoptosis triggered by H~2~O~2~. The results showed that the expression of the Us5 gene encoding protein inhibits apoptosis induced by H~2~O~2~ and inhibits the H~2~O~2~-induced activation of caspase-3/7 and caspase-9, suggesting that the Us5 gene may inhibit the intrinsic pathway. The DPV CHv-BAC parental viruses and the DPV CHv-BAC-ΔgJR rescue viruses induces apoptosis DEF cells that were similar in number. The apoptosis cells induced by DPV CHv-BAC-ΔgJ mutant viruses more than the parental viruses. However, some studies have shown that Us5 can inhibit the extrinsic pathway. In one study, the removal of Us5 from HSV-1 significantly abolished protection against Fas-mediated apoptosis and partially reduced protection against UV radiation by inhibiting caspase-3/8 activation^[@CR50]^. In addition transfecting Us5 has been found to inhibit Fas/UV-induced apoptosis and to weaken the activation of caspases^[@CR18]^. Overall, the results suggested that Us5 is sufficient to establish an antiapoptotic phenotype. Us5-deleted HSV-1 shows a weakened protective effect against cytotoxic T lymphocyte-induced apoptosis, and gJ is sufficient to inhibit F~0~F~1~ ATP synthase activity and the production of ROS to inhibit apoptosis^[@CR51]^. However, the mechanism by which DPV Us5 blocks apoptosis remains elusive. Others should further study the underlying mechanism through the use of additional apoptosis models other than H~2~O~2~-induced apoptosis.

In summary, this study found that the DPV Us5 gene is a late gene and that the Us5 protein is a component of the virion, is localized mainly in the cytoplasm, and can inhibit apoptosis induced by H~2~O~2~.

Materials and Methods {#Sec12}
=====================

Virus, cells, and other significant materials {#Sec13}
---------------------------------------------

The CHv strain of DPV (GenBank accession number: JQ647509), DPV CHv-BAC parental viruses, DPV CHv-BAC-ΔgJ mutant viruses, CHv-BAC-gJR mutant viruses *E*. *coli* DH5α cells, the prokaryotic expression vector pCAGGS, the recombinant β-actin plasmid, duck anti-DPV serum, and rabbit anti-Us5 serum were preserved and provided by our laboratory. The DEF monolayer was incubated at 37 °C with 5% CO~2~ in Minimal Essential Medium (MEM, Gibco) containing 10% newborn calf serum (NBS, Gibco) and 100 μg/mL streptomycin. After DPV infection, the cells were cultured in MEM supplemented with 3% NBS. DPV operation under BSL-2.

Plasmid construction and transfection {#Sec14}
-------------------------------------

The Us5 gene fragment was ligated into the pCAGGS plasmid by homologous recombination using a ClonExpress® II One Step Cloning Kit. DEFs were transiently transfected in 6-well plates with 2.5 μg of the pCAGGS-Us5 recombinant plasmid using 5 μl of Lipofectamine 3000 transfection reagent (Thermo Scientific, Massachusetts, USA) according to the manufacturer's guidelines. At 48 h after transfection, the supernatants of the DEF lysates were collected and stored at −80 °C until further use. The control group included the supernatant collected from DEFs transfected with the empty pCAGGS plasmid. The expression levels of the pCAGGS-Us5 plasmids were confirmed by Western blotting. The primers were designed with software of PRIMER 5 and are listed in Table [2](#Tab2){ref-type="table"}.Table 2Primers.PrimerSequence (5′ → 3′)Product (bp)Us5 amplification primers FCATCATTTTGGCAAAGAATTCGCCACCATGGCCATGTATACAGACGTTACGGTC1701Us5 amplification primers RTTGGCAGAGGGAAAAAGATCTTCAAGCGTAATCTGGAACATCGTATGGGTATACCATACAAAGGCATAUs5 identified primers FAATGTCATGTCGCAACGCTAGATA156Us5 identified primers RTGTCCGCCACAGTCTGATTGATACaspase-3 qPCR primers FTGGTGTTGAGGCAGACAGTGGA113Caspase-3 qPCR primers RCATTCCGCCAGGAGTAATAGCCCaspase-9 qPCR primers FGCTGCTTCAACTTCCTCCGTA166Caspase-9 qPCR primers RCATCTCCACGGACAGACAAAGGβ-actin qPCR primers FCGGGCATCGCTGACA177β-actin qPCR primers RGGATTCATCATACTCCTGCTTTGCTUs2 primers FAGACGGTTCCGAAAGTACAG111Us2 primers RTCGGCAGCACCAATAATCC

Isolation of RNA and analysis of Us5, caspase-3, and caspase-9 mRNA expression by RT-PCR {#Sec15}
----------------------------------------------------------------------------------------

Total RNA was extracted from DPV-infected DEFs at different time points post infection (6 h, 12 h, 24 h, 36 h, 48 h, 54 h, and 60 h). The DEFs included H~2~O~2~-treated cells and mock-treated cells as well as transfected and nontransfected H~2~O~2~-treated cells, and the total RNA was extracted using RNAiso Plus (TaKaRa, Dalian, China) according to the manufacturer's instructions. Extracted RNA was immediately reverse transcribed into first-strand cDNA using a PrimeScript RT Reagent Kit with gDNA Eraser (TaKaRa, Dalian, China). For RT-PCR, a 20 µL total reaction volume was used that contained 10 µL of SYBR Premix Ex Taq II (Tli RNaseH Plus), 1 µL of forward primer, 1 µL of reverse primer, 6 µL of RNase-free water and 2 µL of cDNA. The thermal cycling program included an initial denaturation step for 30 seconds at 95 °C followed by 40 cycles of 5 seconds at 95 °C and 30 seconds at the melting temperature of the specific primer pair. Triplicate experiments were performed to analyze the gene expression of Us5 and β-actin, and the relative transcription level of the DPV Us5 gene was calculated using the 2^−ΔCt^ method simplified from the 2^−ΔΔCt^ method^[@CR28]^. The relative expression levels of caspase-3 and caspase-9 were determined using β-actin as an endogenous control with the comparative Ct (−2^ΔΔin^) method and a real-time thermal cycler (CFX96 Bio-Rad, Hercules, CA, USA)^[@CR52]^. The primers were designed with PRIMER 5 software and are listed in Table [2](#Tab2){ref-type="table"}.

Pharmacological inhibition tests {#Sec16}
--------------------------------

Pharmacological inhibition tests were performed to confirm the kinetics of DPV Us5^[@CR27],[@CR53]^. Four bottles of DEFs were prepared. Three were inoculated with DPV; one bottle contained no drugs, one bottle contained 300 μg/mL GCV (a DNA polymerase synthesis inhibitor), and one bottle contained 100 μg/mL CHX (a protein synthesis inhibitor). The fourth bottle contained untreated mock-infected cells. The infected cells were harvested 24 h after infection and washed twice with PBS. Total RNA was extracted and cDNA was synthesized as described above for RT-PCR. The Us5 gene type was identified by PCR (Us2 was used as a late gene control)^[@CR29]^. The primers were designed with PRIMER 5 software and are listed in Table [2](#Tab2){ref-type="table"}.

Us5 expression analysis by Western blotting {#Sec17}
-------------------------------------------

Western blotting was conducted as described in a previous study^[@CR54]^. DEFs transfected with the empty pCAGGS plasmid and the pCAGGS-Us5 plasmid were collected at 48 h, and the protein expression was confirmed by Western blotting. A duck anti-DPV polyclonal antibody (at a final dilution of 1:500) was used as the primary antibody, and a goat anti-duck IgG antibody (at a final dilution of 1:2000) was used as the secondary antibody. In addition, DPV-infected cells and noninfected cells were collected at 6 h, 12 h, 24 h, 36 h, 48 h, 54 h, and 60 h, and the protein expression was confirmed by Western blotting^[@CR27]^. A rabbit anti-DPV-Us5 polyclonal antibody (at a final dilution of 1:1000) was used as the primary antibody, and a goat anti-rabbit IgG antibody (at a final dilution of 1:3000) was used as the secondary antibody.

Subcellular localization of DPV Us5 by IFA {#Sec18}
------------------------------------------

IFA was conducted using a standard procedure^[@CR27]^. Briefly, pCAGGS-Us5 plasmid-transfected cells and pCAGGS plasmid-transfected cells were collected at 48 h, and DPV-infected cells and noninfected cells were collected at 6 h, 12 h, 24 h, 36 h, 48 h, 54 h, and 60 h. The cells were fixed with 4% paraformaldehyde in PBS for 30 min, washed three times with PBST, permeabilized with 0.25% Triton X-100 in PBS for 30 min at 4 °C and blocked for 1 h with 5% BSA PBS at 37 °C. Additionally, the cells were incubated for 1 h with the rabbit anti-DPV-Us5 polyclonal antibody at a 1:400 dilution at 37 °C. After the cells were washed, a 1:1000 dilution of goat anti-rabbit IgG-FITC secondary antibody was prepared in 1% BSA PBS and incubated with the cells for 1 h at 37 °C. Then, the cell nuclei were stained with DAPI for 15 min at room temperature. Finally, The cytoskeleton were stained with Phalloidin for 30 min at room temperature. After the coverslips were sealed on glass slides with glycerin buffer, the cells were examined with a confocal microscope (Nikon A1, Japan).

DAPI staining of nuclei {#Sec19}
-----------------------

DAPI staining of nuclei was conducted using a standard procedure^[@CR27]^. Briefly, H~2~O~2~-treated cells and non-H~2~O~2~-treated cells were collected at 12 h and fixed with 4% paraformaldehyde for 60 min. The solution was permeabilized for 30 min and stained with DAPI for 10 min. The nuclei were examined with a confocal microscope (Nikon A1, Japan).

Apoptosis of DEFs detected by TUNEL assay {#Sec20}
-----------------------------------------

Apoptosis was detected using an *in situ* cell apoptosis detection kit (POD) (Boster Biological Technology, USA). Briefly, cells were fixed with 4% paraformaldehyde for 60 min and incubated with the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining reaction mixture containing the enzyme solution and label solution prepared according to the manufacturer's protocol. The chromogenic substrate 3,3′-diaminobenzidine (DAB) was then added to visualize the TUNEL staining. The apoptotic nuclei were yellow, and the apoptotic cells were observed under the microscope.

Caspase-3, caspase-7, and caspase-9 activity detection with a Caspase-Glo 3/7 assay kit and a Caspase-Glo 9 assay kit {#Sec21}
---------------------------------------------------------------------------------------------------------------------

The activity of caspase-3/7 and caspase-9 was measured using a Caspase-Glo 3/7 assay kit and a Caspase-Glo 9 assay kit, respectively (Promega, Madison, Wisconsin, USA), according to the manufacturer's instructions. Briefly, after the treated adherent cells were removed, the cells were collected into EP tubes. The cells were counted with a blood cell counting plate. From each sample, approximately 10,000 cells were added to 100 µL of Caspase-Glo reagent in a 96-well white-wall plate and incubated for 30 min. Luciferase activity was detected with a multifunctional microplate reader (Thermo Scientific, Massachusetts, USA).

Virion purification {#Sec22}
-------------------

DPV-infected DEFs were collected at 48 h and purified by low-speed centrifugation (2000 × g, 20 min, 4 °C) to remove the cell debris. Extracellular DPV virions were harvested by ultracentrifugation (40,000 × g, 2 h, 4 °C) through a 30% (wt/vol) sucrose cushion in a Beckman Ti70 rotor. The band containing virions was collected by isopycnic gradient ultracentrifugation in a continuous 30 to 60% (wt/vol) potassium tartrate gradient in TBS (40,000 × g, 2 h, 4 °C) in a Beckman SW60 rotor, diluted ten-fold in TBS and then pelleted by ultracentrifugation (20,000 × g, 60 min, 4 °C). Finally, the pellet was resuspended in TBS and stored at −80 °C.

Mass spectrometry {#Sec23}
-----------------

Purified virion samples were separated by 12% SDS-PAGE. The gel was stained with Coomassie brilliant blue (Sigma-Aldrich) and sent to Sangon Biotech Company (Shanghai, China) for liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis^[@CR27]^. The details of LC-MS/MS, in-gel trypsin digestion, and the database searches were the same as those described in a previous study^[@CR55]--[@CR57]^.

Flow cytometric analysis of apoptosis {#Sec24}
-------------------------------------

The apoptotic cells were detected by flow cytometry (FCM); 5 µL of Annexin V-Fluorescein isothiocyanate (V-FITC) (BD Pharmingen, USA, 51--65874X) and 5 µL of propidium iodide (PI) (BD Pharmingen, USA, 51-66211E) were added to 100 µL of cell suspension and were incubated at 25 °C in the dark for 15 minutes. Annexin binding buffer (450 µL) (BD Pharmingen, USA, 51-66121E) was added to the mixture, and the percentage of apoptotic cells was assayed by FCM within 1 hour. Cell cycle was detected by FCM.

Statistical analysis {#Sec25}
--------------------

The data are expressed as the means ± S.D. Statistical analysis was performed with Student's t-test (GraphPad Prism 6); \*p \< 0.05 and \*\*p \< 0.01 indicate statistical significance compared with the control.
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